Non-Invasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials

Hepatology- United States

doi 10.1002/hep.29797

Full Text

Abstract

Available in

Categories

Date

August 1, 2018

Authors

Cyrielle Caussy

Scott B. Reeder

Claude B. Sirlin

Publisher

Wiley

Related search

Quantifying Fat Replacement of Muscle by Quantitative MRI in Muscular Dystrophy

Journal of Neurology

English

Emerging New Standard for Non-Invasive Assessment of Liver Disease Mortality in Non-Alcoholic Fatty Liver Disease

HepatoBiliary Surgery and Nutrition

English

Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Journal of General Internal Medicine

Internal Medicine

English

425. In Vivo Non-Invasive Tracking of Cell-Based Therapies by Cellular MRI

Molecular Therapy

Molecular Medicine

Molecular Biology

English

Letter About: Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Journal of General Internal Medicine

Internal Medicine

English

MRI as Non-Invasive Modality of Choice for Diagnosis of Cause in Case of Chyluria

Open Journal of Nephrology

English

Quantitative Imaging Assessment for Clinical Trials in Oncology

Journal of the National Comprehensive Cancer Network : JNCCN

English

Non-Invasive Investigation of Tumor Metabolism and Acidosis by MRI-CEST Imaging

Frontiers in Oncology

Cancer Research

English

HCC Screening: Assessment of an Abbreviated Non-Contrast MRI Protocol

European radiology experimental

Nuclear Medicine

English